1 completed, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow Genmab: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer TIVDAK - Cervical Cancer | Phase 4 | Recruiting | Pfizer | 100 | 2025-05-07 | 2026-10-13 |
| Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL) Ofatumumab - Leukaemia, Lymphocytic, Chronic | Phase 4 | Completed | GlaxoSmithKline | 29 | 2009-01-01 | 2014-05-14 |
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases, Female (1) · Leukemia, B-Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Neoplasms by Site (1) · Urogenital Diseases (1) · Uterine Cervical Diseases (1) · Uterine Cervical Neoplasms (1) · Uterine Diseases (1) · Uterine Neoplasms (1)
ofatumumab (1)
Puerto Rico (1) · Sweden (1) · United States (1)